event,time
22 years old ,0
    man ,0
    presented to emergency department ,0
    diagnosed with mild COVID-19 illness ,-1032
    sore throat ,-1032
    loss of sense of smell ,-1032
    positive COVID-19 PCR ,-1032
    full recovery ,-1032
    negative PCR ,-1032
    received first dose of inactivated SARS-CoV-2 vaccine ,-1008
    remained asymptomatic and well ,-1008
    received second dose of inactivated SARS-CoV-2 vaccine ,-336
    started to experience headache ,-336
    started to experience fatigue ,-336
    started to develop fever ,-312
    started to develop sore throat ,-312
    started to develop abdominal pain ,-312
    illness progressed over the following 4 days ,-264
    presented to emergency department ,0
    high-grade fever ,0
    myalgia ,0
    nausea ,0
    vomiting ,0
    diarrhoea ,0
    faint erythematous non'itchy rash over torso ,0
    dry irritant cough ,0
    no shortness of breath ,0
    no chest discomfort ,0
    no urinary symptoms ,0
    no pain ,0
    no swelling of joints ,0
    no history of recent travel ,0
    no sick contacts ,0
    no animal exposure ,0
    no consumption of raw dairy products ,0
    not on chronic medications ,0
    no known allergies ,0
    reported taking ibuprofen ,0
    reported taking one dose of antibiotic ,0
    non-smoker ,0
    did not use recreational drugs ,0
    temperature of 39Â°C ,0
    systolic blood pressure of 110 mm Hg ,0
    tachycardia ,0
    dry mucous membranes ,0
    congested throat ,0
    bilateral conjunctival injection ,0
    left conjunctival haemorrhage ,0
    generalised erythematous maculopapular rash ,0
    peripheral lymph nodes not enlarged ,0
    no audible cardiac murmurs ,0
    chest clear to auscultation ,0
    abdomen examination unremarkable ,0
    WBC 15 ,0
    platelet 122 ,0
    creatinine 115 ,0
    AST 53 ,0
    ALT 81 ,0
    direct bilirubin 35 ,0
    albumin 16 ,0
    C reactive protein 249 ,0
    ferritin 4357 ,0
    D-dimer 14 ,0
    procalcitonin 9 ,0
    interleukin-6 90 ,0
    SARS-CoV-2 PCR negative ,0
    SARS-CoV-2 IgG strongly positive ,0
    throat swab negative for group A streptococcus ,0
    sputum culture showed mixed flora ,0
    bacterial blood cultures negative ,0
    urinalysis showed significant proteinuria ,0
    ANA negative ,0
    dsDNA negative ,0
    c-ANCA negative ,0
    p=ANCA negative ,0
    C3 reduced ,0
    C4 reduced ,0
    admitted to intensive care unit ,0
    hypotension ,0
    diagnosis of probable sepsis ,0
    diagnosis of vaccine-related illness ,0
    treated with ceftriaxone ,0
    treated with levofloxacin ,0
    intravenous fluids ,0
    intravenous hydrocortisone ,0
    hydrocortisone stopped ,48
    blood pressure stabilised ,0
    fever initially improved ,0
    fever remained persistent ,0
    started to develop facial puffiness ,0
    started to develop generalised body oedema ,0
    remained tachycardic ,0
    diarrhoea persisted ,0
    difficult to mobilise ,0
    renal impairment ,0
    significant proteinuria ,0
    ECG showed sinus tachycardia ,0
    ECG showed non-specific T-wave abnormalities ,0
    troponin-I raised ,0
    pro-BNP over 8000 pg/mL ,0
    transthoracic echocardiogram showed severe tricuspid regurgitation ,0
    transthoracic echocardiogram showed normal tricuspid valve structure ,0
    pulmonary hypertension ,0
    PASP 46 mm Hg ,0
    right atrium moderately dilated ,0
    right ventricle moderately dilated ,0
    normal systolic function ,0
    left ventricle cavity size normal ,0
    mildly reduced ejection fraction ,0
    thin rim of pericardial effusion ,0
    computed tomography scan negative for pulmonary embolism ,0
    bilateral moderate pleural effusion ,0
    basal atelectasis ,0
    hydrocortisone discontinued ,48
    shifted to medical ward ,48
    high-level fever began to recur ,48
    all cultures negative ,0
    other workup unrevealing ,0
    multisystem inflammatory syndrome in adults ,0
    multisystem involvement ,0
    cardiac involvement ,0
    renal involvement ,0
    haematologic involvement ,0
    dermatologic involvement ,0
    ophthalmologic involvement ,0
    raised inflammatory markers ,0
    therapy with intravenous dexamethasone ,168
    condition improved ,168
    generalised oedema subsided ,168
    skin rash resolved ,168
    conjunctivitis resolved ,168
    white blood cell count normalised ,168
    renal function improved ,168
    inflammatory markers normalised ,168
    repeat transthoracic echocardiography showed trace tricuspid regurgitation ,168
    marked improvement in right ventricular systolic function ,168
    normal size of right atrium ,168
    normal size of right ventricle ,168
    pulmonary artery systolic pressure normalised ,168
    dexamethasone continued ,168
    switched to oral prednisolone ,192
    discharged home ,192
    tapering dose of prednisolone ,192
    symptoms resolved ,432
    some general weakness ,432
    fatigue ,432
    repeat echocardiogram completely normal ,432
